This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT,
HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A,
product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT.
Current and Emerging Products
- Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays.
- Review of automated and semi-automated molecular and immunohematology analyzers.
- Assessment of current and emerging technologies, and their potential
applications for the blood banking market.
- Comprehensive lists of companies developing or marketing new technologies and products, by test.
Blood Group Genotyping
PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing
BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing
- New product development opportunities for blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 400 pages and 12 tables
SIMILAR MARKET STUDIES
2017 Singapore Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
Summary This new comprehensive report from VPGMarketResearch.com contains 225 pages and 5 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores business and technological trends; provides specimen, sales and volume forecasts for 40 tests; compares ...
January 2017 | $0 | View Details >>
2016 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges-Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market
Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. “2016 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market” is VPGMarketResearch’s new seven-country report designed to help current suppliers and ...
October 2015 | $15900 | View Details >>
Adenovirus: 2015-2019 Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment-France, Germany, Italy, Japan, Spain, UK, USA-Hospitals, Commercial and Public Health Labs, POC Locations
This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Adenovirus tests performed in the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health LabsIn addition to test ...
August 2015 | $0 | View Details >>
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost ...
July 2015 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research